BioSpace News Archive

In collaboration with leading publishers, Digital Science’s ReadCube is announcing the launch of an unprecedented new initiative to facilitate access to literature relevant to COVID-19 research. The COVID-19 Research Pass (CRP) programme provides direct access to over 26 million articles and is available to anyone studying or writing about COVID-19.

CareCentrix, the leader in home-based and post-acute care (PAC) services, announced the renewal of its NCQA Utilization Management Accreditation

The Company Also Reports a 220% Increase in Customer Inquiries, Over Past 30 days, on its Alibaba Portal Page

Today, the U.S. Food and Drug Administration issued a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine, including serious and potentially life-threatening heart rhythm problems, that have been reported with their use for the treatment or prevention of COVID-19, for which they are not approved by the FDA.

- Myovant Sciences submits New Drug Application (NDA) to the FDA for once-daily, oral relugolix (120 mg) for the treatment of men with advanced prostate cancer. - Myovant announces positive results from Phase 3 SPIRIT 2 study evaluating once-daily relugolix combination therapy (relugolix 40 mg plus estradiol 1.0 mg and norethindrone acetate 0.5 mg) in women with endometriosis and from a separate ovulation inhibition study. - Myovant expects to submit an NDA for once-daily rel

BioChek, the specialist company to offer innovative and user-friendly veterinary diagnostic tools, today announced the successful acquisition of BIOTECON, specialised in development and manufacturing of PCR based solutions for food safety diagnostics. The merger creates a new, leading global player in Veterinary and Food

Aesthetic Medical International Holdings Group Limited, a leading provider of aesthetic medical services in China, announces its financial results for the fourth quarter and fiscal year ended December 31, 2019.

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its subsidiary, MediPharm Labs Australia Pty Ltd (“MediPharm Labs Australia”), has entered into an agreement to supply pharmaceutical-quality (GMP certified),

Enrollment Continues in Phase 3 RELIEF Study, with Interim Results of the First 50 Percent of Participants Expected in September 2020 Topline Results of Approximately 470 Participants with Fibromyalgia Expected in the First Quarter of 2021 NEW YORK, April 24, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that 50 percent of the planned total number of participants have been ran

Sanofi (NASDAQ: SNY; EURONEXT: SAN) Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8719551-sanofi-earnings-results-q1-2020/ Rapid and decisive response to COVID-19 global health crisis Sanofi showed resilience and maintained full business continuity worldwide including it